{"filing":{"accession_number":"0001104659-26-075204","cik":"0001818844","ticker":"DWTX","company_name":"Dogwood Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-17","report_date":null,"primary_document":"dwtx-20260616x8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1818844/000110465926075204/dwtx-20260616x8k.htm"},"events":[{"id":11629,"run_id":10214,"accession_number":"0001104659-26-075204","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Dogwood Therapeutics held its Annual Meeting of Stockholders on June 16, 2026, with shareholders voting on five proposals: election of seven directors, ratification of Forvis Mazars, LLP as auditor, amendment to the Certificate of Incorporation to increase authorized shares, Say-on-Frequency advisory vote, and Say-on-Pay advisory vote. All proposals were approved by the required vote margins.","company_name":"Dogwood Therapeutics, Inc.","ticker":"DWTX","filing_date":"2026-06-17","submitted_at":null,"items":[{"id":8274,"accession_number":"0001104659-26-075204","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Dogwood Therapeutics' Annual Meeting held on June 16, 2026, filed under Item 5.07. The filing reports results on five proposals: election of seven directors, ratification of auditor (Forvis Mazars, LLP), amendment to Certificate of Incorporation to increase authorized shares, Say-on-Frequency advisory vote, and Say-on-Pay advisory vote. All proposals were approved with the required votes. The disclosure includes detailed vote tabulations for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:56:09.206741+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":11630,"run_id":10214,"accession_number":"0001104659-26-075204","anchor_item_number":"5.03","event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.75,"summary":"Dogwood Therapeutics' stockholders approved an amendment to the Certificate of Incorporation at the Annual Meeting on June 16, 2026, which was filed with Delaware on June 17, 2026. The specific substantive content of the amendment is not detailed in the filing.","company_name":"Dogwood Therapeutics, Inc.","ticker":"DWTX","filing_date":"2026-06-17","submitted_at":null,"items":[{"id":8273,"accession_number":"0001104659-26-075204","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.75,"reasoning":"This disclosure describes a routine amendment to the Certificate of Incorporation that was approved by stockholders at the Annual Meeting on June 16, 2026, and filed with Delaware on June 17, 2026. While Item 5.03 amendments are required disclosures, the filing provides no substantive detail about the nature of the amendment itself—only that it was approved and filed. Without knowing the specific content of the amendment (referenced in Proposal 3 and the proxy statement), it cannot be classified into a more specific event type. The disclosure is administrative in nature and would not materially affect a reasonable investor's assessment unless the amendment involved a material governance change (e.g., elimination of a class of stock, significant voting rights modification), which is not indicated here.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:56:09.206741+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8273,"accession_number":"0001104659-26-075204","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.75,"reasoning":"This disclosure describes a routine amendment to the Certificate of Incorporation that was approved by stockholders at the Annual Meeting on June 16, 2026, and filed with Delaware on June 17, 2026. While Item 5.03 amendments are required disclosures, the filing provides no substantive detail about the nature of the amendment itself—only that it was approved and filed. Without knowing the specific content of the amendment (referenced in Proposal 3 and the proxy statement), it cannot be classified into a more specific event type. The disclosure is administrative in nature and would not materially affect a reasonable investor's assessment unless the amendment involved a material governance change (e.g., elimination of a class of stock, significant voting rights modification), which is not indicated here.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:56:09.206741+00:00","company_name":"Dogwood Therapeutics, Inc.","ticker":"DWTX","filing_date":"2026-06-17"},{"id":8274,"accession_number":"0001104659-26-075204","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Dogwood Therapeutics' Annual Meeting held on June 16, 2026, filed under Item 5.07. The filing reports results on five proposals: election of seven directors, ratification of auditor (Forvis Mazars, LLP), amendment to Certificate of Incorporation to increase authorized shares, Say-on-Frequency advisory vote, and Say-on-Pay advisory vote. All proposals were approved with the required votes. The disclosure includes detailed vote tabulations for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:56:09.206741+00:00","company_name":"Dogwood Therapeutics, Inc.","ticker":"DWTX","filing_date":"2026-06-17"}]}